Skip to main content
Signal8

Hypha Labs, Inc. (FUNI)

Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cultivate beneficial mushrooms for dietary intake. Founded in 2010, the company is officially based in Las Vegas, Nevada.

Sector: Services-Testing Laboratories

Industry: Medical - Diagnostics & Research

Hypha Labs, Inc. logo

Hypha Labs, Inc.

OTC:FUNIHealthcare
+0.00%$0.0020
Mkt Cap$328K
EV-
Float150.57M
O/S163.9M
VOL3K sh
$ Vol$6
RVOL0.03×
Inst Own-
Net Cash/Sh-
Dilution

Hypha Labs, Inc. (FUNI) dilution facts from SEC filings

Snapshot as of Jun 30, 2026, built from 5 SEC filings.

Shelf registration
None on file in the filings reviewed
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
7 warrant series recorded as outstanding
Most recent offering
Offering, closed Jun 30, 2026
Source: 10-Q filed Aug 14, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro